NZSE - Delayed Quote NZD

Ryman Healthcare Limited (RYM.NZ)

4.1500 -0.1100 (-2.58%)
At close: April 26 at 5:00 PM GMT+12
Key Events
Loading Chart for RYM.NZ
DELL
  • Previous Close 4.2600
  • Open 4.2600
  • Bid 4.1300 x 160200
  • Ask 3.8000 x 74800
  • Day's Range 4.1200 - 4.2600
  • 52 Week Range 4.1200 - 6.9900
  • Volume 352,843
  • Avg. Volume 871,653
  • Market Cap (intraday) 2.854B
  • Beta (5Y Monthly) 0.75
  • PE Ratio (TTM) 10.38
  • EPS (TTM) 0.4000
  • Earnings Date May 26, 2024
  • Forward Dividend & Yield 0.21 (3.95%)
  • Ex-Dividend Date Dec 8, 2022
  • 1y Target Est 6.83

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.

www.rymanhealthcare.co.nz

7,200

Full Time Employees

March 31

Fiscal Year Ends

Recent News: RYM.NZ

Performance Overview: RYM.NZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RYM.NZ
29.66%
S&P/NZX 50 INDEX GROSS ( GROSS
0.29%

1-Year Return

RYM.NZ
21.40%
S&P/NZX 50 INDEX GROSS ( GROSS
1.09%

3-Year Return

RYM.NZ
67.34%
S&P/NZX 50 INDEX GROSS ( GROSS
6.68%

5-Year Return

RYM.NZ
59.94%
S&P/NZX 50 INDEX GROSS ( GROSS
18.12%

Compare To: RYM.NZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RYM.NZ

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    2.85B

  • Enterprise Value

    5.33B

  • Trailing P/E

    10.27

  • Forward P/E

    19.12

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.07

  • Price/Book (mrq)

    0.59

  • Enterprise Value/Revenue

    8.79

  • Enterprise Value/EBITDA

    13.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.63%

  • Return on Assets (ttm)

    0.03%

  • Return on Equity (ttm)

    5.90%

  • Revenue (ttm)

    616.65M

  • Net Income Avi to Common (ttm)

    250.54M

  • Diluted EPS (ttm)

    0.4000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    33.3M

  • Total Debt/Equity (mrq)

    51.83%

  • Levered Free Cash Flow (ttm)

    -110.35M

Research Analysis: RYM.NZ

Analyst Price Targets

5.29
6.83 Average
4.1500 Current
8.25 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: RYM.NZ

People Also Watch